Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aura Biosciences (AURA) Non Operating Income (2021 - 2026)

Aura Biosciences filings provide 6 years of Non Operating Income readings, the most recent being $2000.0 for Q1 2026.

  • Quarterly Non Operating Income fell 99.87% to $2000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Mar 2026, up 37.41% year-over-year, with the annual reading at $6.7 million for FY2025, 5690.0% up from the prior year.
  • Non Operating Income hit $2000.0 in Q1 2026 for Aura Biosciences, down from $1.7 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.8 million in Q4 2023 and bottomed at -$37000.0 in Q4 2024.
  • Average Non Operating Income over 5 years is $929588.2, with a median of $348000.0 recorded in 2022.
  • The largest annual shift saw Non Operating Income surged 52800.0% in 2022 before it crashed 109.2% in 2023.
  • Aura Biosciences' Non Operating Income stood at $1.1 million in 2022, then surged by 164.61% to $2.8 million in 2023, then crashed by 101.33% to -$37000.0 in 2024, then skyrocketed by 4675.68% to $1.7 million in 2025, then crashed by 99.88% to $2000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Non Operating Income are $2000.0 (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025).